Scientists are testing a counterintuitive way to fight mesothelioma, an aggressive asbestos-linked cancer with few effective treatments. A new experimental mesothelioma drug kills cancer cells by disabling PRX3, an antioxidant defense that tumors use to survive intense oxidative stress. In an early clinical trial, it controlled disease progression in 67% of patients and produced encouraging survival results, raising hopes that the strategy could…
Researchers at the University of Vermont have developed a new experimental drug for the treatment of mesothelioma, an aggressive cancer associated with exposure to asbestos. The innovative approach uses the antioxidant defenses of the cells...